Published in Nature on July 12, 1979
The use of FK-506 for small intestine allotransplantation. Inhibition of acute rejection and prevention of fatal graft-versus-host disease. Transplantation (1990) 2.79
Prevention of graft-versus-host disease following allogeneic bone marrow transplantation in rats using FK506. Transplantation (1991) 1.95
FK 506 reverses acute graft-versus-host disease after allogeneic bone marrow transplantation in rats. Surgery (1991) 1.49
Effect of cyclosporin A on the survival of corneal grafts in rabbits. Br J Ophthalmol (1980) 1.44
Graft-versus-host disease in cyclosporin A-treated rats after syngeneic and autologous bone marrow reconstitution. J Exp Med (1983) 1.41
Cyclosporin a. Inhibition of experimental autoimmune uveitis in Lewis rats. J Clin Invest (1981) 1.40
Inhibition by cyclosporin A of rodent malaria in vivo and human malaria in vitro. Infect Immun (1982) 1.10
Cyclosporin A: a powerful immunosuppressant. Can Med Assoc J (1982) 1.09
Effects of immunosuppression on avian coccidiosis: cyclosporin A but not hormonal bursectomy abrogates host protective immunity. Infect Immun (1987) 1.08
Pathogenetic difference between collagen arthritis and adjuvant arthritis. J Exp Med (1984) 1.02
Suppression of delayed-type hypersensitivity reactions and lymphokine production by cyclosporin A in the mouse. Clin Exp Immunol (1983) 0.98
Stage-selective inhibition of rodent malaria by cyclosporine. Antimicrob Agents Chemother (1988) 0.84
Immune reconstitution and graft-versus-host reactions in rat models of allogeneic hematopoietic cell transplantation. Front Immunol (2012) 0.83
An in vitro model for cyclosporin A-induced interference of intrathymic clonal elimination. J Exp Med (1990) 0.80
Effect of cyclosporin A on the anti-leukaemia action associated with graft-versus-host disease. Br J Cancer (1983) 0.80
Mouse models in bone marrow transplantation and adoptive cellular therapy. Semin Hematol (2013) 0.75
Potential role of cyclosporin A in corneal grafting. J R Soc Med (1981) 0.75
Inhibitory effect of cyclosporin A on peripheral blood and bone marrow T lymphocyte colony formation. Clin Exp Immunol (1981) 0.75
Interleukin-2 effect on the inhibition of mixed lymphocyte reaction induced by cyclosporin A. Korean J Intern Med (1987) 0.75
An examination of the cytotoxic effects of silica on macrophages. J Exp Med (1966) 8.42
Cooperating and controlling functions of thymus-derived lymphocytes in relation to autoimmunity. Lancet (1971) 7.98
Cytotoxic t cells in cytomegalovirus infection: HLA-restricted T-lymphocyte and non-T-lymphocyte cytotoxic responses correlate with recovery from cytomegalovirus infection in bone-marrow-transplant recipients. N Engl J Med (1982) 5.72
Role of contractile microfilaments in macrophage movement and endocytosis. Nat New Biol (1971) 4.82
Antibodies to cachectin/tumor necrosis factor reduce interleukin 1 beta and interleukin 6 appearance during lethal bacteremia. J Exp Med (1989) 4.66
Macrophages and age-dependent resistance to Herpes simplex virus in mice. J Immunol (1970) 4.15
Membrane fusion. Biochim Biophys Acta (1973) 3.75
Selective effects of anti-macrophage serum, silica and anti-lymphocyte serum on pathogenesis of herpes virus infection of young adult mice. J Immunol (1970) 3.49
Kaposi's sarcoma-associated human herpesvirus-8 encodes homologues of macrophage inflammatory protein-1 and interleukin-6. Nat Med (1997) 3.44
Glucocorticoids selectively inhibit the transcription of the interleukin 1 beta gene and decrease the stability of interleukin 1 beta mRNA. Proc Natl Acad Sci U S A (1988) 3.34
M-antiglobulins (rheumatoid-factor-like globulins) and other gamma-globulins in relation to tropical parasitic infections. Lancet (1966) 3.31
Requirement of thymus-dependent lymphocytes for potentiation by adjuvants of antibody formation. Nature (1971) 3.30
Acyclovir prophylaxis of herpes-simplex-virus infections. N Engl J Med (1981) 3.19
Identification of human mononuclear leucocyte populations by esterase staining. Clin Exp Immunol (1977) 3.12
Protection of mice against Babesia and Plasmodium with BCG. Nature (1976) 3.01
Asbestos induces selective release of lysosomal enzymes from mononuclear phagocytes. Nature (1974) 2.86
Dengue viruses and mononuclear phagocytes. II. Identity of blood and tissue leukocytes supporting in vitro infection. J Exp Med (1977) 2.84
Extensive prolongation of rabbit kidney allograft survival after short-term cyclosporin-A treatment. Lancet (1978) 2.80
Changes in cellular enzyme levels and extracellular release of lysosomal acid hydrolases in macrophages exposed to group A streptococcal cell wall substance. J Exp Med (1974) 2.72
Effects of antilymphocyte serum on virus oncogenesis. Proc Soc Exp Biol Med (1968) 2.63
Effects of activated complement components on enzyme secretion by macrophages. Immunology (1976) 2.63
Babesia microti and Plasmodium berghei yoelii infections in nude mice. Nature (1974) 2.55
Antibody responses to antigenic determinants of influenza virus hemagglutinin. I. Thymus dependence of antibody formation and thymus independence of immunological memory. J Exp Med (1974) 2.54
An adjuvant formulation that selectively elicits the formation of antibodies of protective isotypes and of cell-mediated immunity. J Immunol Methods (1986) 2.50
Potentiation by silica of the growth of Mycobacterium tuberculosis in macrophage cultures. Br J Exp Pathol (1968) 2.48
A survey of Epstein-Barr virus DNA in lymphoid tissue. Frequent detection in Hodgkin's disease. Am J Clin Pathol (1989) 2.48
Association of BK viruria with hemorrhagic cystitis in recipients of bone marrow transplants. N Engl J Med (1986) 2.47
Interactions of antibodies, complement components and various cell types in immunity against viruses and pyogenic bacteria. Transplant Rev (1974) 2.45
Symposium on immunosuppressive drugs. Immunosuppressive drugs. I. Fed Proc (1967) 2.44
Venoocclusive disease of the liver following bone marrow transplantation. Transplantation (1987) 2.35
Mechanism of immunologic resistance to herpes simplex virus 1 (HSV-1) infection. J Immunol (1976) 2.34
Physico-chemical properties of silica in relation to its toxicity. Nature (1966) 2.32
Thalidomide for the treatment of chronic graft-versus-host disease. N Engl J Med (1992) 2.31
Lymphocytes binding human thyroglobulin in healthy people and its relevance to tolerance for autoantigens. Lancet (1973) 2.28
Isolation and characterisation of resistant Herpes simplex virus after acyclovir therapy. Lancet (1982) 2.28
Protection of mice against Babesia spp. and Plasmodium spp. with killed Corynebacterium parvum. Parasitology (1977) 2.28
Antibody responses to antigenic determinants of influenza virus hemagglutinin. II. Original antigenic sin: a bone marrow-derived lymphocyte memory phenomenon modulated by thymus-derived lymphocytes. J Exp Med (1974) 2.25
Mechanisms by which activated macrophages inhibit lymphocyte responses. Immunol Rev (1978) 2.24
Syndrome of idiopathic hyperammonemia after high-dose chemotherapy: review of nine cases. Am J Med (1988) 2.19
Nature of the effector cells responsible for antibody-dependent cell-mediated killing of Cryptococcus neoformans. Infect Immun (1976) 2.16
Heterophile antibodies, M-antiglobulins and immunoglobulins in experimental trypanosomiasis. Clin Exp Immunol (1969) 2.16
The acute splanchnic and peripheral tissue metabolic response to endotoxin in humans. J Clin Invest (1990) 2.08
A role of macrophages in the stimulation of immune responses by adjuvants. J Immunol (1969) 2.06
Lichenoid chronic graft-vs-host disease occurring in a dermatomal distribution. Arch Dermatol (1994) 2.05
Role of contractile microfilaments in the release of histamine from mast cells. Nature (1972) 1.99
Role of lysosomes and of cell membranes in photosensitization. Nature (1966) 1.91
The inhibition of phagocytosis and facilitation of exocytosis in rabbit polymorphonuclear leukocytes by cytochalasin B. Lab Invest (1973) 1.89
The role of cell-mediated immune responses in resistance to malaria, with special reference to oxidant stress. Annu Rev Immunol (1983) 1.88
Antibacterial antibodies in rectal and colonic mucosa in ulcerative colitis. Lancet (1971) 1.88
Fc receptors induced by herpes simplex virus. I. Biologic and biochemical properties. J Immunol (1978) 1.85
Ability of activated complement components to induce lysosomal enzyme release from macrophages. Nature (1976) 1.85
Predictors of death from chronic graft-versus-host disease after bone marrow transplantation. Blood (1989) 1.85
Mineral fibers: chemical, physicochemical, and biological properties. Adv Pharmacol Chemother (1975) 1.83
Dual role of tumor necrosis factor-alpha in angiogenesis. Am J Pathol (1992) 1.82
Zymosan-induced arthritis: a model of chronic proliferative arthritis following activation of the alternative pathway of complement. Arthritis Rheum (1977) 1.82
Complement activation by the alternative pathway and macrophage enzyme secretion in the pathogenesis of chronic inflammation. Immunology (1977) 1.82
Tissue thromboplastin activity of isolated human monocytes. Thromb Haemost (1978) 1.81
Mode of action of adjuvants: effects on antibody responses to macrophage-associated bovine serum albumin. J Immunol (1970) 1.79
Immune responses in mice with murine leprosy. Clin Exp Immunol (1970) 1.79
The graft versus host reaction in man after bone marrow transplantation: pathology, pathogenesis, clinical features, and implication. Clin Immunol Immunopathol (1973) 1.78
Marrow transplantation for acute nonlymphocytic leukemia after treatment with busulfan and cyclophosphamide. N Engl J Med (1983) 1.75
Genetic factors in resistance against virus infections. Arch Gesamte Virusforsch (1965) 1.74
Role of macrophages and antibody in resistance of mice against yellow fever virus. J Immunol (1971) 1.71
HLA-restricted cytotoxic T lymphocyte and nonthymic cytotoxic lymphocyte responses to cytomegalovirus infection of bone marrow transplant recipients. J Immunol (1981) 1.69
Mechanisms of endocytosis and exocytosis. Symp Soc Exp Biol (1974) 1.69
The role of thymus-dependent immunity in Mycoplasma pulmonis infections of mice. J Med Microbiol (1972) 1.69
Colonization and infection with Trichosporon species in the immunosuppressed host. J Infect Dis (1983) 1.69
The role of antibody and host cells in the resistance of mice against infection by coxsackie B-3 virus. J Gen Virol (1973) 1.68
Role of T lymphocytes in recovery from murine cytomegalovirus infection. Infect Immun (1977) 1.68
Unresponsiveness to self antigens. Lancet (1971) 1.67
Theta-sensitive cell and erythropoiesis: identification of a defect in W/Wv anemic mice. Science (1977) 1.67
Lymphocyte-selective cytostatic and immunosuppressive effects of mycophenolic acid in vitro: role of deoxyguanosine nucleotide depletion. Scand J Immunol (1991) 1.67
Cyclosporin A and the thymus. Immunopathology. Am J Pathol (1987) 1.65
Infectious gastroenteritis in bone-marrow-transplant recipients. N Engl J Med (1982) 1.64
Immune complexes induce selective release of lysosomal hydrolases from macrophages. Nature (1974) 1.64
The role of microfilaments and microtubules in cell movement, endocytosis and exocytosis. Ciba Found Symp (1973) 1.61
Monoclonal antibodies to human recombinant interleukin 1 (IL 1)beta: quantitation of IL 1 beta and inhibition of biological activity. J Immunol (1987) 1.61
Pathogenesis of the chronic inflammatory lesion induced by group A streptococcal cell walls. Lab Invest (1974) 1.60
Serum containing tumor necrosis factor is cytotoxic for the human malaria parasite Plasmodium falciparum. Infect Immun (1983) 1.60
Immunity and immunopathology in virus infections. Ann Inst Pasteur (Paris) (1972) 1.60
Participation of mononuclear phagocytes in chronic inflammatory diseases. J Reticuloendothel Soc (1974) 1.59
Pharmacokinetics of busulfan: correlation with veno-occlusive disease in patients undergoing bone marrow transplantation. Cancer Chemother Pharmacol (1989) 1.57
RS-61443--a new, potent immunosuppressive agent. Transplantation (1991) 1.57
On the role of mononuclear phagocytes in immunity against viruses. Prog Med Virol (1974) 1.55
Role of mononuclear infiltrating cells in pathogenesis of hepatitis. Lancet (1978) 1.52
The eye in bone marrow transplantation. VI. Retinal complications. Arch Ophthalmol (1994) 1.51
The eye in bone marrow transplantation. I. Clinical study. Arch Ophthalmol (1983) 1.51
Ocular manifestations of graft-vs-host disease. Ophthalmology (1983) 1.50